Dihexa vs Semax

Side-by-side comparison of Dihexa, Semax — mechanism, dosing, half-life, side effects, and research status.

← Pick different peptides
Attribute Dihexa Dihexa (PNB-0408) Cognitive Semax Semax (Heptapeptide ACTH Analogue) Cognitive
Basics
Molecular type HGF/MET PotentiatorACTH-Derived Neuropeptide
Amino acids —7
Molecular weight 413.5 Da813.9 Da
Half-life Long-acting (days)~minutes (nasal); longer CNS retention
Route(s) Oral, Transdermal, Subcutaneous (research)Intranasal, Subcutaneous
Mechanism & Research
Primary mechanism Dihexa binds to and potentiates the HGF/MET signalling axis. HGF-MET signalling drives synaptogenesis — the formation of new neural connections. By dramatically amplifying this pathway, Dihexa promotes dendritic spine de… Semax's primary mechanism involves upregulation of brain-derived neurotrophic factor (BDNF) — a neurotrophin critical for neuronal survival, synaptic plasticity, and neurogenesis. In animal models, Semax increases BDNF m…
Research status Research Compound Research Compound
Evidence summary Dihexa research is primarily from Washington State University's McCoy group. Dramatic findings in animal models have generated interest, but human clinical trials are not yet published. Anecdotal reports from users are b… Semax has been investigated in Russian clinical research since the 1980s. It has been approved in Russia as a drug for stroke, TBI, and cognitive decline. Western research interest has grown, but large RCTs meeting curre…
Protocol & Dosing
Typical dose 10–15 mg/day (oral or transdermal)200–600 mcg/day (intranasal)
Frequency Daily or 5 days on / 2 days off1–2x daily
Duration 4–8 weeks2–4 weeks cycles
Timing MorningMorning (or morning + midday); avoid evening to prevent sleep disruption
Safety
Common side effects
  • Overstimulation (anxiety, irritability at high doses)
  • Headache
  • Insomnia if taken late in day
  • Nasal irritation
  • Mild stimulation/anxiety (dose-dependent)
  • Headache (initial)
  • Temporary appetite change
Contraindications
  • Active cancer (HGF/MET is a tumour growth pathway — significant theoretical concern)
  • Personal/family history of certain cancers (MET-driven tumours)
  • Pregnancy
  • Active psychiatric conditions (bipolar, schizophrenia)
  • Epilepsy/seizure disorders
  • Pregnancy
Anti-doping Not Prohibited Not Prohibited
Deeper reading
Related peptides Semax, Selank, P21 Selank, Dihexa, P21
Full profile Read full Dihexa profile → Read full Semax profile →

Comparison data is compiled from each peptide’s individual profile. All values are drawn from peer-reviewed research and regulatory sources. For educational use only — not medical advice. Verify any protocol with a qualified healthcare provider.